Elicera Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	244	59	90	70	99	-
Market Cap Growth	205.12%	-35.03%	29.73%	-29.98%	-	-
Enterprise Value	209	28	64	31	46	-
Last Close Price	5.03	1.67	4.56	3.52	5.02	-
PS Ratio	17.83	8.22	8.03	54.32	169174.86	-
PB Ratio	8.05	2.82	5.50	2.12	1.90	-
P/TBV Ratio	8.05	2.82	5.50	2.12	1.90	-
EV/Sales Ratio	15.28	3.92	5.73	24.39	78418.50	-
Asset Turnover	0.40	0.25	0.29	0.03	0	-
Quick Ratio	5.35	4.01	2.16	3.27	21.04	5.10
Current Ratio	5.35	4.06	2.19	3.39	21.68	5.12
Return on Equity (ROE)	-48.58%	-86.68%	-66.66%	-45.72%	-42.00%	-52.04%
Return on Assets (ROA)	-25.08%	-36.55%	-27.94%	-23.95%	-24.36%	-26.77%
Return on Capital Employed (ROCE)	-45.30%	-81.30%	-104.20%	-59.00%	-25.10%	-27.60%
Earnings Yield	-5.34%	-27.49%	-18.18%	-27.96%	-13.21%	-
Buyback Yield / Dilution	-52.64%	-59.89%	0.40%	-23.97%	-32.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.